Rapidly Progressive Stage IV Lung Adenocarcinoma With a Miliary Imaging Pattern

This lung cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Adenocarcinoma
Biomarkers
TTF-1-positive; p40-negative; chromogranin-negative; synaptophysin-negative; EGFR-negative; ALK-negative; ROS1-negative; PD-L1 expression 5%–10%.
Sex
Male
Treatment
radiation and supportive care
Outcome
In Memory

Treatment course, step by step

  1. Whole-brain radiation therapy was given for multiple brain lesions considered suspicious for metastases.
  2. Pembrolizumab, carboplatin, and pemetrexed were considered but never started because the disease progressed too rapidly.
  3. Hospice care was arranged as his functional status deteriorated.

What happened, in summary

A 64-year-old man presented after two to three weeks of dry cough, frontal headache, and generalized muscle and joint pain. His history included successfully treated prostate cancer, hepatitis C, and more than 50 pack-years of cigarette use. Chest imaging showed innumerable tiny pulmonary nodules in a miliary pattern, which initially raised a broad differential including infection and metastatic disease.

Tissue obtained from a lymph node supported primary lung adenocarcinoma. The tumor was TTF-1-positive and negative for p40, chromogranin, and synaptophysin. Molecular testing found no EGFR, ALK, or ROS1 alteration, and PD-L1 expression was 5%–10%. He was diagnosed with stage IV lung adenocarcinoma. Brain MRI showed at least six small enhancing lesions considered suspicious for metastases, and he received whole-brain radiation with minimal improvement.

At first, bone imaging was negative and he denied bone pain. About one month later, his functional status declined sharply and he developed diffuse body pain; additional imaging suggested new bone and liver involvement. A combination of pembrolizumab, carboplatin, and pemetrexed was considered, but the disease progressed too quickly for treatment to begin.

He died approximately four months after diagnosis while being transported to inpatient hospice. The report emphasized the unusual miliary appearance and the aggressive course of his EGFR-negative lung cancer.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar lung cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more lung cancer stories